Volpara Health Technologies Limited

Equities

VHT

NZVHTE0001S6

Advanced Medical Equipment & Technology

Delayed Australian S.E. 02:10:11 2024-05-03 am EDT 5-day change 1st Jan Change
1.145 AUD +0.44% Intraday chart for Volpara Health Technologies Limited 0.00% +3.62%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Volpara Health Technologies Narrows Fiscal 2024 Loss as Revenue Rises 22% MT
Lunit Implements Scheme to Acquire Volpara Health Technologies MT
Volpara Health Technologies Limited(ASX:VHT) dropped from S&P/ASX Emerging Companies Index CI
Volpara to Delist After Court Approves Acquisition by Lunit MT
Volpara Health Technologies Secures Approval for Lunit’s Proposed Takeover MT
Transcript : Volpara Health Technologies Limited - Shareholder/Analyst Call
Volpara Health Technologies Limited Launches MQSA Compliance Software at the Society for Breast Imaging Symposium CI
Volpara Health Technologies Ltd. to Showcase AI Software for Breast Centers at NCBC 2024 CI
Volpara Health Technologies Ltd. to Highlight Growing Ai Suite for Mammography At ECR 2024, Including New Lunit Distribution Agreement CI
Lunit to Take Over Volpara Health; Lunit Shares Decline 4% MT
Lunit Inc. agreed to acquire Volpara Health Technologies Limited from Harbour Asset Management Limited and others for AUD 300 million. CI
Transcript : Volpara Health Technologies Limited, H1 2024 Earnings Call, Nov 21, 2023
Volpara Health Technologies Limited Reports Earnings Results for the Half Year Ended September 30, 2023 CI
Transcript : Volpara Health Technologies Limited, Q2 2024 Earnings Call, Oct 17, 2023
Volpara Health Technologies Divests Interest in Software Company RevealDX MT
An Unknown buyer acquired 4% stake in Reveal DX fromVolpara Health Technologies Limited. CI
Transcript : Volpara Health Technologies Limited - Shareholder/Analyst Call
Transcript : Volpara Health Technologies Limited, Q1 2024 Earnings Call, Jul 21, 2023
Volpara Health Technologies Secures AU$1.4 Million Contract for Mammography Screening Software MT
Transcript : Volpara Health Technologies Limited, 2023 Earnings Call, May 25, 2023
Volpara Health Technologies Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Transcript : Volpara Health Technologies Limited, Q4 2023 Earnings Call, Apr 28, 2023
Volpara Health Technologies Expands Contract With US Hospital Systems Operator; Shares Up 6% MT
Volpara Health Technologies Updates Contract with US Imaging Provider; Shares Fall 5% MT
Volpara Health Technologies Ltd. to Showcase Comprehensive Product Offerings at NCoBC 2023 CI
Chart Volpara Health Technologies Limited
More charts
Volpara Health Technologies Limited is a New Zealand-based company, which makes software for healthcare providers to understand cancer risk, enabling patients to make personal care decisions and guide recommendations about additional imaging, genetic testing and other interventions. Its artificial intelligence (AI)-powered image analysis enables radiologists to quantify breast tissue with precision and helps technologists produce mammograms with optimal image quality, positioning, compression and dose. Its software streamlines operations and provides performance insights that support continuous quality improvement. Its software is used in over 2,000 facilities by more than 5,600 technologists, impacting nearly 15 million patients globally. It helps providers conduct more than three million cancer risk assessments each year and can be deployed stand-alone or fully integrated with electronic health record systems, mammography reporting systems, imaging hardware and genetic laboratories.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
2
Last Close Price
1.145 AUD
Average target price
0.92 AUD
Spread / Average Target
-19.65%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. VHT Stock
  4. News Volpara Health Technologies Limited
  5. Volpara Health Technologies Secures Approval for Lunit’s Proposed Takeover